Literature DB >> 34185298

Sweat Gland Tumor Microenvironment.

Adeodatus Yuda Handaya1, Sumadi Lukman Anwar2, Aditya Rifqi Fauzi3, Victor Agastya Pramudya Werdana3.   

Abstract

Malignant sweat gland tumors are rare cutaneous neoplasms and associated with poor prognosis. The process of tumorigenesis originating from sweat glands is complex and dynamic. The tumor is surrounded by an extracellular matrix (ECM) and stromal cells, as well as physiological state from the tumor microenvironment (TME). Various types of evidence suggest a variety of vital components of TME that interact with each other, ranging from fibroblasts, immune and inflammatory cells, vascular and lymphatic networks, and ECM. This chapter provides a comprehensive overview of sweat gland tumor microenvironment based on current studies of TME and describes the function of each component of TME in cancer initiation, progression, and invasion.

Entities:  

Keywords:  Angiogenesis; Apocrine; Cancer progression; Chronic inflammation; Eccrine; Extracellular matrix; Immune suppression; Lymphangiogenesis; MMPs; Metastasis; Mutation; Sweat gland tumor; Tumor microenvironment; Tumor-associated macrophages; Tumorigenesis

Mesh:

Year:  2020        PMID: 34185298     DOI: 10.1007/978-3-030-59038-3_16

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  52 in total

Review 1.  Tumor microenvironment and cancer therapy resistance.

Authors:  Yu Sun
Journal:  Cancer Lett       Date:  2015-08-10       Impact factor: 8.679

2.  p53 mutations in sweat gland carcinomas.

Authors:  W Biernat; A Peraud; L Wozniak; H Ohgaki
Journal:  Int J Cancer       Date:  1998-05-04       Impact factor: 7.396

3.  Cutaneous appendageal carcinoma incidence and survival patterns in the United States: a population-based study.

Authors:  Patrick W Blake; Porcia T Bradford; Susan S Devesa; Jorge R Toro
Journal:  Arch Dermatol       Date:  2010-06

4.  A potential role for targeted therapy in a subset of metastasizing adnexal carcinomas.

Authors:  Dora Dias-Santagata; Quynh Lam; Kristin Bergethon; Gabrielle M Baker; A John Iafrate; Dinesh Rakheja; Mai P Hoang
Journal:  Mod Pathol       Date:  2011-03-18       Impact factor: 7.842

5.  Tumor microenvironment complexity: emerging roles in cancer therapy.

Authors:  Melody A Swartz; Noriho Iida; Edward W Roberts; Sabina Sangaletti; Melissa H Wong; Fiona E Yull; Lisa M Coussens; Yves A DeClerck
Journal:  Cancer Res       Date:  2012-03-13       Impact factor: 12.701

6.  Cutaneous hidradenocarcinoma: a clinicopathological, immunohistochemical, and molecular biologic study of 14 cases, including Her2/neu gene expression/amplification, TP53 gene mutation analysis, and t(11;19) translocation.

Authors:  Dmitry V Kazakov; Doina Ivan; Heinz Kutzner; Dominic V Spagnolo; Petr Grossmann; Tomas Vanecek; Radek Sima; Denisa Kacerovska; Ksenia V Shelekhova; Natalja Denisjuk; Uwe Hillen; Naoto Kuroda; Petr Mukensnabl; Dusan Danis; Michal Michal
Journal:  Am J Dermatopathol       Date:  2009-05       Impact factor: 1.533

7.  Apocrine-eccrine carcinomas: molecular and immunohistochemical analyses.

Authors:  Long P Le; Dora Dias-Santagata; Amanda C Pawlak; Arjola K Cosper; Anh Thu Nguyen; M Angelica Selim; April Deng; Nora K Horick; A John Iafrate; Martin C Mihm; Mai P Hoang
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

8.  Successful Treatment of Advanced Primary Cutaneous Apocrine Carcinoma on the Scrotum with Systemic Chemotherapy and Radiotherapy Followed by Denosumab.

Authors:  Sadanori Furudate; Taku Fujimura; Akira Tsukada; Yota Sato; Takanori Hidaka; Kayo Tanita; Yumi Kambayashi; Takahiro Haga; Akira Hashimoto; Setsuya Aiba
Journal:  Case Rep Oncol       Date:  2017-01-16

9.  Malignant adnexal tumors of the skin: a single institution experience.

Authors:  Tolutope Oyasiji; Wei Tan; John Kane; Joseph Skitzki; Valerie Francescutti; Kilian Salerno; Nikhil I Khushalani
Journal:  World J Surg Oncol       Date:  2018-05-30       Impact factor: 2.754

10.  Wide excision and reconstruction surgery for recurrent sweat gland umbilical adenocarcinoma followed by chemotherapy can prevent the risk of recurrences.

Authors:  Adeodatus Yuda Handaya; Nova Yuli Prasetyo Budi; Guntur Marganing Adi Nugroho; Aditya Rifqi Fauzi
Journal:  BMC Surg       Date:  2018-10-12       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.